UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (159) 159
life sciences & biomedicine (154) 154
humans (146) 146
oncology (109) 109
female (70) 70
male (69) 69
aged (65) 65
middle aged (62) 62
lung cancer (58) 58
adult (56) 56
respiratory system (53) 53
lung neoplasms - drug therapy (52) 52
lung neoplasms - pathology (47) 47
tumors (44) 44
carcinoma, non-small-cell lung - drug therapy (41) 41
cancer (40) 40
biological and medical sciences (39) 39
aged, 80 and over (38) 38
chemotherapy (38) 38
medical sciences (38) 38
cough (37) 37
care and treatment (36) 36
pneumology (31) 31
tumors of the respiratory system and mediastinum (30) 30
antineoplastic combined chemotherapy protocols - therapeutic use (29) 29
small cell lung cancer (26) 26
lung neoplasms - genetics (25) 25
general & internal medicine (24) 24
evidence-based medicine (23) 23
treatment outcome (23) 23
abridged index medicus (22) 22
animals (22) 22
carcinoma, non-small-cell lung - pathology (22) 22
neoplasm staging (22) 22
lung neoplasms - mortality (21) 21
lung cancer, non-small cell (20) 20
patients (20) 20
clinical trials (19) 19
pulmonary/respiratory (19) 19
research (19) 19
small cell lung carcinoma - pathology (19) 19
antineoplastic agents - therapeutic use (18) 18
disease-free survival (18) 18
hematology, oncology and palliative medicine (18) 18
mutation (18) 18
prognosis (18) 18
analysis (17) 17
carcinoma, non-small-cell lung - genetics (17) 17
non-small cell lung cancer (17) 17
critical care medicine (16) 16
lung neoplasms - therapy (16) 16
protein kinase inhibitors - therapeutic use (16) 16
radiotherapy (16) 16
cancer therapies (15) 15
carcinoma, non-small-cell lung - mortality (15) 15
cough - etiology (15) 15
pulmonary and respiratory medicine (15) 15
guidelines (14) 14
lung neoplasms - metabolism (14) 14
nsclc (14) 14
quality of life (14) 14
respiratory tract diseases (14) 14
diagnosis (13) 13
metastasis (13) 13
neoplastic cells, circulating - pathology (13) 13
risk factors (13) 13
usage (13) 13
cell line, tumor (12) 12
mice (12) 12
small cell lung carcinoma - drug therapy (12) 12
antineoplastic combined chemotherapy protocols - adverse effects (11) 11
biopsy (11) 11
health aspects (11) 11
lung neoplasms - radiotherapy (11) 11
medicine & public health (11) 11
young adult (11) 11
antineoplastic agents - administration & dosage (10) 10
biomarkers, tumor - blood (10) 10
cisplatin - administration & dosage (10) 10
clinical trials as topic (10) 10
disease progression (10) 10
lung cancer, small cell (10) 10
lung neoplasms - diagnosis (10) 10
pharmacology & pharmacy (10) 10
pharmacology. drug treatments (10) 10
survival analysis (10) 10
antineoplastic agents - pharmacology (9) 9
biomarker (9) 9
biomarkers (9) 9
biomarkers, tumor - metabolism (9) 9
cancer patients (9) 9
cough - therapy (9) 9
kaplan-meier estimate (9) 9
medicin och hälsovetenskap (9) 9
neoplastic cells, circulating - metabolism (9) 9
non-small-cell lung cancer (9) 9
practice guidelines as topic (9) 9
research article (9) 9
review (9) 9
survival rate (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 0028-4793, 12/2014, Volume 371, Issue 23, pp. 2167 - 2177
General aspects | Tumors of the respiratory system and mediastinum | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors | Pneumology | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Guanine - analogs & derivatives | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Protein Kinase Inhibitors - adverse effects | Cisplatin - administration & dosage | Pyridines - adverse effects | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Pyrazoles - adverse effects | Pyridines - therapeutic use | Kaplan-Meier Estimate | Carboplatin - administration & dosage | Adenocarcinoma - drug therapy | Carcinoma, Non-Small-Cell Lung - mortality | Pemetrexed | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Glutamates - administration & dosage | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Adenocarcinoma - mortality | Guanine - administration & dosage | Crizotinib | Treatment outcome | Chemotherapy | Usage | Care and treatment | Lung cancer | Analysis | Dosage and administration | Comparative analysis | Risk factors | Cancer | Appetite | Edema | Inhibitor drugs | Intravenous administration | Biomedical research | Diarrhea | Non-small cell lung carcinoma | Fatigue | Nausea | Metastasis | Patients | Cisplatin | Quality of life | Lungs | Platinum | Vomiting | Comparative studies | Carboplatin | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
The New England journal of medicine, ISSN 0028-4793, 06/2013, Volume 368, Issue 25, pp. 2385 - 2394
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Tumors of the respiratory system and mediastinum | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors | Pneumology | Glutamates - therapeutic use | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Glutamates - adverse effects | Guanine - analogs & derivatives | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Young Adult | Taxoids - therapeutic use | Pyridines - adverse effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Guanine - adverse effects | Guanine - therapeutic use | Taxoids - adverse effects | Pyrazoles - adverse effects | Pyridines - therapeutic use | Kaplan-Meier Estimate | Carcinoma, Non-Small-Cell Lung - mortality | Pemetrexed | Disease-Free Survival | Protein Kinase Inhibitors - therapeutic use | Quality of Life | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Tyrosine | Intravenous administration | Biomedical research | Lung cancer | Liver | Fatigue | Chromosome rearrangements | Cancer therapies | Patients | Lymphoma | Metastases | Ovarian cancer | Quality of life | Confidence intervals | Chemotherapy | Dyspnea | Alopecia | Platinum | Respiration | Pharmaceutical industry | Protein-tyrosine kinase | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article